HT-2157
HT-2157 (former development code SNAP-37889) is a drug which acts as a selective non-peptide antagonist for the receptor GAL-3, which is usually activated by the neuropeptide galanin. Blocking this receptor with HT-2157 produced increased serotonin release,[1] as well as producing antidepressant and anxiolytic effects in animal studies,[2] and it was also being researched for treatment of cognitive dysfunction.[3] All human clinical trials were terminated due to safety concerns however, and new GAL-3 antagonists are now being sought instead.[4]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
Chemical and physical data | |
Formula | C21H13F3N2O |
Molar mass | 366.343 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
References
- "pA2 Online". www.pa2online.org.
- Swanson, C. J.; Blackburn, T. P.; Zhang, X.; Zheng, K.; Xu, Z.-Q. D.; Hokfelt, T.; Wolinsky, T. D.; Konkel, M. J.; Chen, H.; Zhong, H.; Walker, M. W.; Craig, D. A.; Gerald, C. P. G.; Branchek, T. A. (2005). "Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299". Proceedings of the National Academy of Sciences. 102 (48): 17489–17494. doi:10.1073/pnas.0508970102. PMC 1283534. PMID 16287967.
- US 8277842, Kaplan AP, "Enteric-coated HT-2157 compositions and methods of their use", published January 20, 2012
- "Dart NeuroScience LLC -- Scientific Advisory Board". www.dartneuroscience.com.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.